Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMC 125526)

Published in EMBO J on July 02, 2001

Authors

K Petersson1, M Håkansson, H Nilsson, G Forsberg, L A Svensson, A Liljas, B Walse

Author Affiliations

1: Molecular Biophysics, Centre for Chemistry and Chemical Engineering, Lund University, PO Box 124, S-221 00 Lund, Sweden.

Articles citing this

Bacterial superantigens. Clin Exp Immunol (2003) 2.42

Thermal stability and structural changes in bacterial toxins responsible for food poisoning. PLoS One (2017) 1.37

TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30

Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol (2012) 1.15

Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity, superantigenic activity, and correlation to antibiotic resistance. Toxins (Basel) (2010) 1.10

A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med (2003) 1.10

Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med (2003) 1.05

Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex. Structure (2004) 0.99

Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule. J Biol Chem (2006) 0.95

A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol (2007) 0.91

The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation. Nat Commun (2010) 0.89

Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen. J Biol Chem (2006) 0.88

Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun (2014) 0.87

The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens. J Biol Chem (2010) 0.83

Structure, properties, and engineering of the major zinc binding site on human albumin. J Biol Chem (2009) 0.83

Structure of Staphylococcal Enterotoxin E in Complex with TCR Defines the Role of TCR Loop Positioning in Superantigen Recognition. PLoS One (2015) 0.82

Mutagenesis, biochemical, and biophysical characterization of Mycoplasma arthritidis-derived mitogen. Mol Immunol (2006) 0.82

Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators. Infect Immun (2005) 0.81

Crystal structure of staphylococcal enterotoxin G (SEG) in complex with a mouse T-cell receptor {beta} chain. J Biol Chem (2010) 0.81

Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity. Immunology (2002) 0.79

The systemic and pulmonary immune response to staphylococcal enterotoxins. Toxins (Basel) (2010) 0.79

Crystal structure of a dimeric form of streptococcal pyrogenic exotoxin A (SpeA1). Protein Sci (2004) 0.78

Uptake and intracellular trafficking of superantigens in dendritic cells. PLoS One (2013) 0.77

Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes. Protein Sci (2015) 0.75

Transcytosis, Antitumor Activity and Toxicity of Staphylococcal Enterotoxin C2 as an Oral Administration Protein Drug. Toxins (Basel) (2016) 0.75

Two common structural motifs for TCR recognition by staphylococcal enterotoxins. Sci Rep (2016) 0.75

Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen. PLoS One (2014) 0.75

Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1. Toxins (Basel) (2017) 0.75

Articles cited by this

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47

The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69

The staphylococcal enterotoxins and their relatives. Science (1990) 11.99

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (1994) 7.13

Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60

The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol Lett (1998) 2.63

Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science (1994) 2.24

Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun (1998) 2.22

X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity (1997) 2.07

Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J (2000) 2.00

Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99

Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med (1999) 1.98

Rational modification of enzyme catalysis by engineering surface charge. Nature (1987) 1.71

Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68

Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J (1995) 1.54

Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr Purif (1999) 1.50

Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42

A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39

Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol (1997) 1.37

Zinc regulates the function of two superantigens. Proc Natl Acad Sci U S A (1992) 1.32

Microbial superantigens: from structure to function. Trends Microbiol (2000) 1.31

The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure (1997) 1.26

Transcytosis of staphylococcal superantigen toxins. J Exp Med (1997) 1.20

Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol (2000) 1.17

The crystallography beamline I711 at MAX II. J Synchrotron Radiat (2000) 1.07

Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J Immunol (1996) 1.05

Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med (1996) 1.04

The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules. J Mol Biol (2000) 1.00

Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J Mol Biol (2000) 0.99

Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli. J Biol Chem (1997) 0.95

Staphylococcal enterotoxin H displays unique MHC class II-binding properties. J Immunol (1999) 0.94

T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J Exp Med (1994) 0.94

Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J Immunol (1998) 0.93

Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins. J Immunol (1995) 0.83

Articles by these authors

Refined structure of human carbonic anhydrase II at 2.0 A resolution. Proteins (1988) 4.32

Crystal structure of human carbonic anhydrase C. Nat New Biol (1972) 4.10

Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol (2004) 3.03

Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus. EMBO J (1994) 2.78

Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH. Proteins (1988) 2.73

Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. J Mol Biol (1992) 2.70

Structure of phosphate-free ribonuclease A refined at 1.26 A. Biochemistry (1988) 2.53

Crystal structure of catechol O-methyltransferase. Nature (1994) 2.49

Letter: Recognition of structural domains in globular proteins. J Mol Biol (1974) 2.42

Remote sensing and image analysis in plant pathology. Annu Rev Phytopathol (1995) 2.14

Factors of importance to Doppler indices of left ventricular filling in 50-year-old healthy subjects. Eur Heart J (1996) 2.04

Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J (1995) 1.99

Characterization of the binding sites of protein L11 and the L10.(L12)4 pentameric complex in the GTPase domain of 23 S ribosomal RNA from Escherichia coli. J Mol Biol (1990) 1.97

[Report of a case. Inhalation steroids caused adrenal cortex suppression]. Lakartidningen (1997) 1.93

Structure-function relationships in lactate dehydrogenase. Proc Natl Acad Sci U S A (1973) 1.87

Crystal structure of Thermotoga maritima ribosome recycling factor: a tRNA mimic. Science (1999) 1.82

Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78

Role of membrane potential in the response of rat small mesenteric arteries to exogenous noradrenaline stimulation. J Physiol (1982) 1.74

Hypothesis for the initiation of vasomotion. Circ Res (2001) 1.70

The ribosomal protein L8 is a complex L7/L12 and L10. FEBS Lett (1976) 1.68

Structure of the C-terminal domain of the ribosomal protein L7/L12 from Escherichia coli at 1.7 A. J Mol Biol (1987) 1.68

Inhibition of cytotoxicity of lymphocytes by concanavalin A in vitro. Science (1970) 1.59

Clothing convective heat exchange--proposal for improved prediction in standards and models. Ann Occup Hyg (1999) 1.55

Crystal structure of the haloalkane dehalogenase from Sphingomonas paucimobilis UT26. Biochemistry (2000) 1.48

Crystal structure of the ribosomal protein S6 from Thermus thermophilus. EMBO J (1994) 1.47

The influence of the sympathetic impulse pattern on contractile responses of rat mesenteric arteries and veins. Acta Physiol Scand (1985) 1.43

The structure of elongation factor G in complex with GDP: conformational flexibility and nucleotide exchange. Structure (1996) 1.43

Normal serum activities of liver enzymes in Swedish paint industry workers with heavy exposure to organic solvents. Br J Ind Med (1985) 1.39

Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci U S A (1994) 1.38

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31

Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry. Biomed Mass Spectrom (1980) 1.22

Fusion proteins in biotechnology. Curr Opin Biotechnol (1992) 1.22

Structural studies of ribosomes. Prog Biophys Mol Biol (1982) 1.20

Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k. Protein Sci (1997) 1.19

Letter: Molecular symmetry axes and subunit interfaces in certain dehydrogenases. J Mol Biol (1973) 1.18

Refined structure of bovine carbonic anhydrase III at 2.0 A resolution. Proteins (1993) 1.16

The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure (1998) 1.16

Crystal structure of the Escherichia coli dUTPase in complex with a substrate analogue (dUDP). Nat Struct Biol (1996) 1.14

The stoichiometry and reconstitution of a stable protein complex from Escherichia coli ribosomes. FEBS Lett (1979) 1.14

Exposure and urinary excretion of aluminum during welding. Scand J Work Environ Health (1985) 1.13

Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport (1995) 1.11

Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int (1994) 1.11

Interplay between superantigens and immunoreceptors. Scand J Immunol (2004) 1.11

De novo design of proteins--what are the rules? Chem Rev (2001) 1.10

Cloning and nucleotide sequence of the cyclic AMP receptor protein-regulated Salmonella typhimurium pepE gene and crystallization of its product, an alpha-aspartyl dipeptidase. J Bacteriol (1994) 1.08

Structural comparison of the prokaryotic ribosomal proteins L7/L12 and L30. Proteins (1988) 1.08

The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J Mol Biol (1996) 1.07

The crystallography beamline I711 at MAX II. J Synchrotron Radiat (2000) 1.07

Archaeal ribosomal protein L1: the structure provides new insights into RNA binding of the L1 protein family. Structure (2000) 1.06

Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry (2006) 1.06

Crystallographic analysis of Thr-200-->His human carbonic anhydrase II and its complex with the substrate, HCO3-. Proteins (1993) 1.06

Crystal structure of human erythrocyte carbonic anhydrase C. 3. Molecular structure of the enzyme and of one enzyme-inhibitor complex at 5-5 A resolution. J Mol Biol (1967) 1.05

Disulfide exchange folding of insulin-like growth factor I. Biochemistry (1992) 1.04

Crystallization of and preliminary X-ray data for an intracellular vitamin A-binding protein from rat liver. J Biol Chem (1981) 1.04

Crystal structure of phospholipase C from Bacillus cereus complexed with a substrate analog. J Mol Biol (1993) 1.04

X-ray analysis of metal-substituted human carbonic anhydrase II derivatives. Acta Crystallogr D Biol Crystallogr (1994) 1.03

The flexible region of protein L12 from bacterial ribosomes studied by proton nuclear magnetic resonance. J Biol Chem (1989) 1.03

Transmitter characteristics of small mesenteric arteries from the rat. Acta Physiol Scand (1990) 1.03

Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood. Drug Metab Dispos (1989) 1.03

Clinical diagnoses and MRI findings in patients with TMD pain. J Oral Rehabil (2007) 1.02

Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med (1994) 1.02

Rhythmic contractions of isolated small arteries from rat: influence of the endothelium. Acta Physiol Scand (1993) 1.01

Mechanisms of Ca2+ sensitization of force production by noradrenaline in rat mesenteric small arteries. J Physiol (1998) 1.01

Crystal structure of the RNA binding ribosomal protein L1 from Thermus thermophilus. EMBO J (1996) 1.01

KCa-channel blockade prevents sustained pressure-induced depolarization in rat mesenteric small arteries. Am J Physiol (1997) 1.01

Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol (2001) 1.00

The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules. J Mol Biol (2000) 1.00

Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. Proteins (1993) 0.99

Crystallization of and preliminary X-ray data for the plasma retinol-binding protein. J Biol Chem (1984) 0.99

Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes. Clin Exp Immunol (1999) 0.99

Drug latentiation of terbutaline. In vitro serum esterase catalyzed hydrolysis of a series of acyl-substituted mono- and diesters of terbutaline. Acta Pharm Suec (1974) 0.98

Crystal structure of a ribosomal component at 2.6 A resolution. Nature (1980) 0.98

Rhythmic contractions of isolated small arteries from rat: role of calcium. Acta Physiol Scand (1993) 0.96

Free cytosolic Ca2+ measured with Ca(2+)-selective electrodes and fura 2 in rat mesenteric resistance arteries. Am J Physiol (1993) 0.96

The use of bead polymerization of acrylic monomers for immobilization of enzymes. Biochim Biophys Acta (1972) 0.96

Functional anion binding sites in dogfish M4 lactate dehydrogenase. J Mol Biol (1973) 0.96

Adrenergic innervation and neurogenic response in large and small arteries and veins from the rat. Acta Physiol Scand (1986) 0.95

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler (2003) 0.94

Effect of acidosis on tension and [Ca2+]i in rat cerebral arteries: is there a role for membrane potential? Am J Physiol (1998) 0.94

Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med (2000) 0.94

Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential. J Physiol (1997) 0.93

Atomic co-ordinates for dogfish M4 apo-lactate dehydrogenase. Biochem Biophys Res Commun (1973) 0.93

X-ray structure of a ribonuclease A-uridine vanadate complex at 1.3 A resolution. Acta Crystallogr D Biol Crystallogr (1997) 0.93

Nonadrenergic noncholinergic vasodilation in bovine ciliary artery involves CGRP and neurogenic nitric oxide. Invest Ophthalmol Vis Sci (1994) 0.93

Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J Immunol (1998) 0.93

An intact conformation at the tip of elongation factor G domain IV is functionally important. FEBS Lett (1998) 0.93

The structure of human carbonic anhydrase II in complex with bromide and azide. FEBS Lett (1993) 0.93

Distension-dependent changes in noradrenaline sensitivity in small arteries from the rat. Acta Physiol Scand (1985) 0.92

Glyoxylic acid condensation: a new fluorescence method for the histochemical demonstration of biogenic monoamines. Acta Physiol Scand (1973) 0.92

Identification of human chromosome regions by aid of computerized pattern analysis. Exp Cell Res (1972) 0.92

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. Clin Cancer Res (2013) 0.92